Weekly Recap | HENGRUI PHARMA +0.34%, most brokers rate it buyWeekly Review·Oct 24, 2026 at 05:07 AM01276+2.20%
Weekly Recap | HENGRUI PHARMA +0.93%, consensus target sits well above spotWeekly Review·Oct 17, 2026 at 05:20 AM01276+2.20%
Weekly Recap | HENGRUI PHARMA -0.79%, EMA accepts filingWeekly Review·Oct 10, 2026 at 05:07 AM01276+2.20%
